Summit Therapeutics
SMMT
#1502
Rank
C$19.20 B
Marketcap
C$25.80
Share price
1.72%
Change (1 day)
-2.27%
Change (1 year)

Summit Therapeutics (SMMT) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.36 Billion

According to Summit Therapeutics 's latest financial reports the company's total assets are C$0.36 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Summit Therapeutics - Total assets on balance sheet (from 2020 to 2020)

Total assets by year

Year Total assets Change
2024-12-31C$0.62 B132.19%
2023-12-31C$0.26 B-70.13%
2022-12-31C$0.90 B523.75%
2021-12-31C$0.14 B10.56%
2020-12-31C$0.13 B
2019-01-31C$0.13 B0.52%
2018-01-31C$0.13 B77.24%
2017-01-31C$76.94 M8.35%
2016-01-31C$71.01 M27.24%
2015-01-31C$55.81 M152.02%
2014-01-31C$22.14 M102.34%
2013-01-31C$10.94 M13.62%
2012-01-31C$9.63 M-24.64%
2011-01-31C$12.78 M-59.41%
2010-01-31C$31.49 M-10.22%
2009-01-31C$35.07 M-74.63%
2008-01-31C$0.13 B29.05%
2007-01-31C$0.10 B104.54%
2006-01-31C$52.39 M-16.59%
2005-01-31C$62.8 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sarepta Therapeutics
SRPT
C$4.83 B 1,234.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$0.33 B-6.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
C$0.71 B 97.35%๐Ÿ‡บ๐Ÿ‡ธ USA